AcquisitionOther
Harrow, Inc. acquired Melt Pharmaceuticals, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Harrow, Inc. -> Melt Pharmaceuticals, Inc.
Strategic expansion of portfolio with non-opioid, non-IV sedation therapies with global patent coverage and potential to enter multi-billion-dollar procedural sedation market.
Open source record (SEC) ↗